机构:[1]School of Nursing, Guangzhou University of Chinese Medicine, Guangzhou 510006, Guangdong, China.[2]Department of Gastroenterology, Guangdong Second Provincial General Hospital, Guangzhou 510030, Guangdong, China.[3]Department of Orthopedic, Traditional Chinese Medicine Hospital, Puning, Jieyang 515300, China.[4]Department of Spine Surgery, Guangdong Second Provincial General Hospital, Guangzhou 510030, Guangdong, China.
Science and Technology
Foundation of Guangzhou (202102020108), Doctoral Station
Fund of Guangdong Second Provincial General Hospital
(Grant nos. 2019BSGZ005 and 2019BSGZ006), and
Youth Foundation of Guangdong Second Provincial General
Hospital (Grant nos. Yq2018-013 and YQ2017-011)
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类|4 区医学
小类|4 区肿瘤学
最新[2025]版:
无
第一作者:
第一作者机构:[1]School of Nursing, Guangzhou University of Chinese Medicine, Guangzhou 510006, Guangdong, China.[2]Department of Gastroenterology, Guangdong Second Provincial General Hospital, Guangzhou 510030, Guangdong, China.
通讯作者:
推荐引用方式(GB/T 7714):
Xiong Man,Wang Mingsen,Yan Youhong,et al.MACC1 Promotes the Progression and Is a Novel Biomarker for Predicting Immunotherapy Response in Colorectal Cancer[J].Journal of oncology.2022,2022:8326940.doi:10.1155/2022/8326940.
APA:
Xiong Man,Wang Mingsen,Yan Youhong,Chen Xiaowu,Guo Wanwei...&Wang Yeyang.(2022).MACC1 Promotes the Progression and Is a Novel Biomarker for Predicting Immunotherapy Response in Colorectal Cancer.Journal of oncology,2022,
MLA:
Xiong Man,et al."MACC1 Promotes the Progression and Is a Novel Biomarker for Predicting Immunotherapy Response in Colorectal Cancer".Journal of oncology 2022.(2022):8326940